Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
Status:
Completed
Trial end date:
2020-03-17
Target enrollment:
Participant gender:
Summary
This research study is evaluating the effectiveness of the drug called cabozantinib (alone or
in combination with trastuzumab) as a possible treatment for advanced breast cancer in which
the cancer has spread to the brain.